80 related articles for article (PubMed ID: 6420560)
21. Plasminogen activator synthesis by cultured human embryonic lung cells: characterization of the suppressive effect of corticosteroids.
Rifkin DB
J Cell Physiol; 1978 Dec; 97(3 Pt 2 Suppl 1):421-8. PubMed ID: 83324
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
24. Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 and cAMP.
Mochan E; Uhl J; Newton R
Arthritis Rheum; 1986 Sep; 29(9):1078-84. PubMed ID: 3019358
[TBL] [Abstract][Full Text] [Related]
25. Cell surface and relative mRNA expression of heat shock protein 70 in human synovial cells.
Sedlackova L; Nguyen TT; Zlacka D; Sosna A; Hromadnikova I
Autoimmunity; 2009 Jan; 42(1):17-24. PubMed ID: 18608178
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids inhibit plasminogen activator production by endothelial cells.
Laug WE
Thromb Haemost; 1983 Dec; 50(4):888-92. PubMed ID: 6420927
[TBL] [Abstract][Full Text] [Related]
28. Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion.
Varani J; Burmeister B; Sitrin RG; Shollenberger SB; Inman DR; Fligiel SE; Gibbs DF; Johnson K
Am J Pathol; 1994 Sep; 145(3):561-73. PubMed ID: 8080040
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
30. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
Lin CW; Robbins PD; Georgescu HI; Evans CH
Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
[TBL] [Abstract][Full Text] [Related]
31. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein.
Wijnberg MJ; Quax PH; Nieuwenbroek NM; Verheijen JH
Thromb Haemost; 1997 Aug; 78(2):880-6. PubMed ID: 9268189
[TBL] [Abstract][Full Text] [Related]
32. Characterization of inhibitors of phosphodiesterase 1C on a human cellular system.
Dunkern TR; Hatzelmann A
FEBS J; 2007 Sep; 274(18):4812-24. PubMed ID: 17697115
[TBL] [Abstract][Full Text] [Related]
33. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
Crutchley DJ; Conanan LB; Maynard JR
J Pharmacol Exp Ther; 1982 Sep; 222(3):544-9. PubMed ID: 7050342
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of macrophage prostaglandin and neutral protease production by phorbol esters as a model for the induction of vascular changes associated with tumor promotion.
Hamilton JA
Cancer Res; 1980 Jul; 40(7):2273-80. PubMed ID: 6770996
[TBL] [Abstract][Full Text] [Related]
36. Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cells.
Kuo BS; Korner G; Bjornsson TD
J Clin Invest; 1988 Mar; 81(3):730-7. PubMed ID: 3125227
[TBL] [Abstract][Full Text] [Related]
37. Streptococcal cell walls and synovial cell activation. Stimulation of synovial fibroblast plasminogen activator activity by monocytes treated with group A streptococcal cell wall sonicates and muramyl dipeptide.
Hamilton JA; Zabriskie JB; Lachman LB; Chen YS
J Exp Med; 1982 Jun; 155(6):1702-18. PubMed ID: 6804590
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Gualandris A; Presta M
J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
[TBL] [Abstract][Full Text] [Related]
39. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells.
Imai T; Hirata Y; Kanno K; Marumo F
J Clin Invest; 1994 Feb; 93(2):543-9. PubMed ID: 7509342
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts.
Cho ML; Cho CS; Min SY; Kim SH; Lee SS; Kim WU; Min DJ; Min JK; Youn J; Hwang SY; Park SH; Kim HY
Arthritis Rheum; 2002 May; 46(5):1202-9. PubMed ID: 12115224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
